<?xml version="1.0" encoding="UTF-8"?>
<fig id="f0030">
 <label>Fig. 6</label>
 <caption>
  <p>X-ray co-crystal structures of SARS-CoV-2 M
   <sup>pro</sup> with covalently binding peptidomimetic inhibitors. M
   <sup>pro</sup> is shown as hydrophobicity surface (red indicating hydrophobic and blue hydrophilic surface areas) and grey ribbon with amino acid side chains (UCSF Chimera).
   <xref rid="b0350" ref-type="bibr">
    <sup>70</sup>
   </xref> Inhibitor groups binding to protease subsites are indicated according to the Schechter Berger nomenclature.
   <xref rid="b0405" ref-type="bibr">
    <sup>81</sup>
   </xref> Electrophilic warheads covalently binding to Cys145 are circled. (a) Compound 
   <bold>3</bold> with an Î±-ketoamide warhead (PDB: 6Y2F). (b) Compound 
   <bold>4</bold> with a Michael acceptor warhead (PDB: 7BQY). (c) Compound 
   <bold>5</bold> with a C-terminal aldehyde warhead (PDB: 6LZE).
  </p>
 </caption>
 <graphic xlink:href="gr6_lrg" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
